Laurent Peyrin-Biroulet to Feces
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Feces.
Connection Strength
0.627
-
Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clin Gastroenterol Hepatol. 2020 07; 18(8):1663-1672.
Score: 0.309
-
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2019 10; 157(4):1032-1043.e1.
Score: 0.073
-
It is Time to Revise the STRIDE Guidelines Determining Therapeutic Goals for Treat-to-Target in Inflammatory Bowel Disease. J Crohns Colitis. 2018 Mar 28; 12(4):509.
Score: 0.067
-
TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice. J Crohns Colitis. 2018 Jan 24; 12(2):230-244.
Score: 0.066
-
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease. Inflamm Bowel Dis. 2017 01; 23(1):126-132.
Score: 0.062
-
Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease. Gut Microbes. 2019; 10(2):149-158.
Score: 0.017
-
Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study. Inflamm Bowel Dis. 2017 11; 23(11):2048-2053.
Score: 0.016
-
Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice. PLoS One. 2017; 12(9):e0184624.
Score: 0.016